Novo Nordisk expects Victoza (liraglutide) to be approved by the FDA in a few months' time. <a href="http://www.reuters.com/article/rbssHealthcareNews/idUSDKT00454620090806" rel="nofollow" target="_blank">http://www.reuters.com/article/rbssHealthcareNews/idUSDKT00454620090806</a>